High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma

Bibliographic Details
Main Authors:	Caroline Louis-Brennetot, Olivier Delattre, Isabelle Janoueix-Lerosey
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420300773

Similar Items

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
by: Francisco M. Vega, et al.
Published: (2020-03-01)

Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
by: Margot Gautier, et al.
Published: (2021-06-01)

Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis.
by: Valentina Boeva, et al.
Published: (2013-01-01)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
by: Si D, et al.
Published: (2020-02-01)

CD44 expression and modulation on human neuroblastoma tumours and cell lines.
by: Gross, N, et al.
Published: (1995)

BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells
by: Jessica Sriha, et al.
Published: (2022-06-01)

Internalization and down-regulation of the ALK receptor in neuroblastoma cell lines upon monoclonal antibodies treatment.
by: Pierre Mazot, et al.
Published: (2012-01-01)

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.
by: Hervé J Brisse, et al.
Published: (2017-01-01)

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
by: Birgit Geoerger, et al.
Published: (2022-08-01)

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
by: Amparo López-Carrasco, et al.
Published: (2021-10-01)

CD44s and CD44v6 expression in head and neck epithelia.
by: Brigitte Mack, et al.
Published: (2008-01-01)

CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
by: Gross, N, et al.
Published: (1994)

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
by: Cécile Thirant, et al.
Published: (2023-05-01)

Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.
by: Anne Guimier, et al.
Published: (2014-01-01)

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
by: Xao X. Tang, et al.
Published: (2021-04-01)

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
by: Damiano Bartolucci, et al.
Published: (2022-09-01)

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
by: Amanda Sosulski, et al.
Published: (2016-01-01)

High Expression of Osteopontin and CD44v6 in Odontogenic Keratocysts
by: Yi-Ping Wang, et al.
Published: (2009-04-01)

Treatment of High-Risk Neuroblastoma
by: Julie Krystal, et al.
Published: (2023-07-01)

Treatment of high-risk neuroblastoma
by: Ki Woong Sung
Published: (2012-04-01)

CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients
by: Gabriela M Almeida, et al.
Published: (2021-09-01)

High Expression of the Lysosomal Protease Cathepsin D Confers Better Prognosis in Neuroblastoma Patients by Contrasting EGF-Induced Neuroblastoma Cell Growth
by: Eleonora Secomandi, et al.
Published: (2022-04-01)

The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer
by: Peng Jiang, et al.
Published: (2024-04-01)

High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma
by: Kenjiro Ogushi, et al.
Published: (2023-09-01)

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
by: Zhanxin Du, et al.
Published: (2022-01-01)

Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
by: Valerio Maggio, et al.
Published: (2018-01-01)

Integrative discovery of treatments for high-risk neuroblastoma
by: Elin Almstedt, et al.
Published: (2020-01-01)

The genetic landscape of high-risk neuroblastoma
by: Lander, Eric Steven
Published: (2014)

High-Risk Neuroblastoma Treatment Review
by: Valeria Smith, et al.
Published: (2018-08-01)

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5
by: Shinji Yamada, et al.
Published: (2018-07-01)

High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection
by: Titapun A, et al.
Published: (2021-06-01)

PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers
by: Kholoud Alwosaibai, et al.
Published: (2023-01-01)

Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
by: Zhenqiu Liu, et al.
Published: (2020-06-01)

Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma
by: Garaventa Alberto, et al.
Published: (2009-12-01)

Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism.
by: Shunsuke Kimura, et al.
Published: (2021-01-01)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
by: Ingrīda Čēma, et al.
Published: (2021-11-01)

High-Risk Neuroblastoma: A Surgical Perspective
by: Jillian C. Jacobson, et al.
Published: (2023-02-01)

Novel drug - dinutuximab for high-risk neuroblastoma
by: Supriya Kushwah, et al.
Published: (2018-01-01)

Expression of ADRB2 in children with neuroblastoma and its influence on prognosis
by: Lijian Cao, et al.
Published: (2022-11-01)

HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44
by: Bo Yang, et al.
Published: (2023-11-01)